Medpace Holdings, Inc.
| Security | MEDP / Medpace Holdings, Inc. |
| Insider | Fred B Jr Davenport |
This page shows the track record and history of DAVENPORT FRED B JR
insider trades in Medpace Holdings, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Fred B Jr Davenport in MEDP / Medpace Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | 500 | 145.8000 | 500 | 145.8000 | 72,900 | 340 | 239.5200 | 46,860 | 64.28 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Fred B Jr Davenport in MEDP / Medpace Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-24 | 1,712 | 301.8200 | 1,712 | 301.8200 | 516,716 | 12 | 288.7700 | -22,341 | -4.32 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-28 | 2025-04-24 | 4 | DAVENPORT FRED B JR | MEDP | Common Stock | D | 301.8200 | -1,712 | -517 | 2,998 | ||||
| 2025-04-28 | 2025-04-24 | 4 | DAVENPORT FRED B JR | MEDP | Common Stock | D | 57.1700 | 4,710 | 269 | 4,710 | ||||
| 2022-05-24 | 2022-05-20 | 4 | DAVENPORT FRED B JR | MEDP | Stock Option (Right to Buy) | D | 133.87 | 1,903 | 1,903 | |||||
| 2022-02-22 | 2022-02-17 | 4 | DAVENPORT FRED B JR By Trust | MEDP | Common Stock | I | 145.8000 | 500 | 73 | 2,000 | ||||
| 2021-05-18 | 2021-05-14 | 4 | DAVENPORT FRED B JR | MEDP | Stock Option (Right to Buy) | D | 164.68 | 1,822 | 1,822 | |||||
| 2020-05-19 | 2020-05-15 | 4 | DAVENPORT FRED B JR | MEDP | Stock Option (Right to Buy) | D | 84.36 | 3,858 | 3,858 | |||||
| 2019-05-21 | 2019-05-17 | 4 | DAVENPORT FRED B JR | MEDP | Stock Option (Right to Buy) | D | 54.99 | 6,472 | 6,472 | |||||
| 2018-08-15 | 3 | DAVENPORT FRED B JR By Trust | MEDP | Common Stock | I | 3,000 | ||||||||
| 2018-08-15 | 3 | DAVENPORT FRED B JR By Trust | MEDP | Common Stock | I | 3,000 | ||||||||
| 2018-08-15 | 3 | DAVENPORT FRED B JR By Trust | MEDP | Common Stock | I | 3,000 | ||||||||
| 2018-08-15 | 2018-08-13 | 4 | DAVENPORT FRED B JR | MEDP | Stock Option (Right to Buy) | D | 57.17 | 4,710 | 4,710 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
